Especially, the prevalence of EGFR, ALK, ROS1 and KRAS mutation was significantly different in NSCLC patients from Qujing City than that from other regions located in Yunnan Province of China [5]. This evidence concerns the gene KRAS and non-small cell lung carcinoma.